{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:02:23Z","timestamp":1791208943520,"version":"4.1.0"},"reference-count":35,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T00:00:00Z","timestamp":1362700800000},"content-version":"vor","delay-in-days":6276,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[1996,1]]},"abstract":"<jats:p>A study of the plasma pharmacokinetics, tumor localization, and safety of a single dose of doxorubicin encapsulated in liposomes containing surface\u2010bound polyethylene glycol (PEG\u2010liposomal doxorubicin) was conducted in patients with Kaposi's sarcoma (KS) as a manifestation of acquired immune deficiency syndrome (AIDS). Eighteen patients with AIDS\u2010KS diagnosed by examination of biopsy specimens were randomly assigned to receive either standard doxorubicin or PEG\u2010liposomal doxorubicin. Consecutive participants were entered at three dose levels (10, 20, and 40 mg\/m<jats:sup>2<\/jats:sup>) in ascending fashion. Clearance of PEG\u2010liposomal doxorubicin was 0.034 L\/h\/m<jats:sup>2<\/jats:sup> to 0.108 L\/h\/m<jats:sup>2<\/jats:sup>, volume of distribution (Vd) was 2.2 L\/m<jats:sup>2<\/jats:sup> to 4.4 L\/m<jats:sup>2<\/jats:sup>, and half\u2010lives (t<jats:sub>1\/2<\/jats:sub>) of the initial decline in the plasma concentration\u2014time curve and of the terminal decline were 3.77 hours and 41.3 hours, respectively. Seventy\u2010two hours after administration, doxorubicin levels observed in lesions of patients receiving PEG\u2010liposomal doxorubicin were 5.2 to 11.4 times greater than those found in patients given comparable doses of standard doxorubicin. PEG\u2010liposomal doxorubicin and standard doxorubicin were roughly equipotent in producing toxicity. Encapsulation in liposomes containing surface\u2010bound PEG significantly limits the distribution and elimination of doxorubicin, results in greater accumulation of the drug in KS lesions 72 hours after dosing than does standard doxorubicin, and may improve drug efficacy and therapeutic index in the treatment of AIDS\u2010KS.<\/jats:p>","DOI":"10.1002\/j.1552-4604.1996.tb04152.x","type":"journal-article","created":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T18:27:12Z","timestamp":1362767232000},"page":"55-63","source":"Crossref","is-referenced-by-count":305,"title":["Doxorubicin Encapsulated in Liposomes Containing Surface\u2010Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS\u2010Related Kaposi's Sarcoma"],"prefix":"10.1002","volume":"36","author":[{"given":"Donald W.","family":"Northfelt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis J.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Working","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Volberding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Amantea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence D.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,3,8]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)90001-L"},{"key":"e_1_2_1_3_2","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1200\/JCO.1994.12.9.1910","article-title":"Improved survival for patients with AIDS\u2010related Kaposi's sarcoma","volume":"12","author":"Miles SA","year":"1994","journal-title":"J Clin Oncol"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(89)80483-8"},{"key":"e_1_2_1_5_2","unstructured":"PlettenbergA StoehrA vanDykU AlbrechtH StellbrinkHJ MeigelW:Increasing risk for opportunistic infections (CDC IV C1) during chemotherapy in patients with Kaposi's sarcoma (abstract). IX International Conference on AIDS Berlin July 1218 1993;PO\u2010B12\u20101557."},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1991.476"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018907715905"},{"key":"e_1_2_1_8_2","first-page":"6774","article-title":"Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C\u201026 colon carcinoma","volume":"52","author":"Huang SK","year":"1992","journal-title":"Cancer Res"},{"key":"e_1_2_1_9_2","first-page":"10","article-title":"Extravasation and transcytosis of liposomes in Kaposi's sarcoma\u2010like dermal lesions of transgenic mice bearing the HIV tat gene","volume":"143","author":"Huang SK","year":"1993","journal-title":"Am J Pathol"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19940501)73:9<2366::AID-CNCR2820730920>3.0.CO;2-6"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.9.1201"},{"key":"e_1_2_1_12_2","volume-title":"Handbook for Reporting Results of Cancer Treatment.","author":"World Health Organization","year":"1979"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0731-7085(88)80111-0"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(00)83842-6"},{"key":"e_1_2_1_15_2","volume-title":"Estimation of a normal probability density function from samples measured with non\u2010neglible and non\u2010constant dispersion (internal report)","author":"Pr\u00e9vost G","year":"1977"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.3109\/03602538409015066"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.3109\/03602538409015063"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-468X(79)90025-4"},{"key":"e_1_2_1_19_2","volume-title":"Adapt Users Guide.","author":"D'Argenio DZ","year":"1992"},{"key":"e_1_2_1_20_2","first-page":"1","volume-title":"Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring.","author":"Jusko WJ","year":"1992"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/66.2.237"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198815010-00002"},{"key":"e_1_2_1_23_2","first-page":"3417","article-title":"Plasma pharmacokinetics of adriamycin and adriamycinol: implications for the design of in vitro experiments and treatment protocols","volume":"43","author":"Greene RF","year":"1983","journal-title":"Cancer Res"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1987.92"},{"key":"e_1_2_1_25_2","first-page":"R665","article-title":"Multiexponential, multicompartment, and noncompartmental modeling. II. Data analysis and statistical considerations","volume":"15","author":"Landaw EM","year":"1984","journal-title":"Am J Physiol"},{"key":"e_1_2_1_26_2","first-page":"987","article-title":"Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene\u2010glycol coated liposomes","volume":"54","author":"Gabizon A","year":"1994","journal-title":"Cancer Res"},{"key":"e_1_2_1_27_2","first-page":"169","article-title":"Distribution and excretion of adriamycin in man","volume":"19","author":"DiFronzo G","year":"1973","journal-title":"Biomedicine"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00570501"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1986.141"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19800501)45:9<2231::AID-CNCR2820450902>3.0.CO;2-3"},{"key":"e_1_2_1_31_2","first-page":"51","article-title":"\u201cStealth\u201d liposomal doxorubicin (SLD) delivers more doxorubicin to AIDS\u2010Kaposi's Sarcoma lesions than to normal skin (abstract)","volume":"13","author":"Northfelt DW","year":"1994","journal-title":"Proc Am Soc Clin Oncol"},{"key":"e_1_2_1_32_2","first-page":"5135","article-title":"Microscopic localization of sterically stabilized liposomes in colon carcinoma\u2010bearing mice","volume":"52","author":"Huang SK","year":"1992","journal-title":"Cancer Res"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00409698"},{"key":"e_1_2_1_34_2","first-page":"95","article-title":"Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules","volume":"133","author":"Dvorak H","year":"1988","journal-title":"Am J Pathol"},{"key":"e_1_2_1_35_2","first-page":"135","article-title":"Passive tumor targeting of soluble macromolecules and drug conjugates","volume":"9","author":"Seymour LW","year":"1992","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/335606a0"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1552-4604.1996.tb04152.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1552-4604.1996.tb04152.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T03:35:31Z","timestamp":1698377731000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1002\/j.1552-4604.1996.tb04152.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1996,1]]}},"alternative-id":["10.1002\/j.1552-4604.1996.tb04152.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1552-4604.1996.tb04152.x","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,1]]}}}